Atopic Dermatitis (14 companies)

Companies with an active program in Atopic Dermatitis.

Ticker	Company	Therapeutic areas	Programs	Lead stage	Mkt cap	Programs
ACRS	Aclaris Therapeutics	DermatologyGI/Hepatology+1 Rare	4	Phase 2	$619M	8
ALDX	Aldeyra Therapeutics	DermatologyOncology+1	1	NDA Submitted	$38.3M	5
APGE	Apogee Therapeutics	DermatologyGI/Hepatology+1 Rare	3	Phase 2	—	9
RCUS	Arcus Biosciences	DermatologyImmunology+1	1	Phase 3	$2.63B	8
CLDX	Celldex Therapeutics	DermatologyImmunology+1	1	Phase 3	$2.35B	9
CRVS	Corvus Pharmaceuticals	DermatologyOncology+1 Rare	1	Phase 3	$889M	7
ENTA	Enanta Pharmaceuticals	DermatologyImmunology+1	1	Approved	$320M	7
EVMN	Evommune	DermatologyImmunology+1	2	Phase 2	$241M	6
IMCR	Immunocore	DermatologyInfectious Disease+2	1	Approved	$1.60B	15
KYMR	Kymera Therapeutics	DermatologyImmunology+1 Rare	1	Phase 2	$11.2B	5
NKTR	Nektar Therapeutics	DermatologyImmunology+2	1	Phase 3	$1.27B	11
TTRX	Turn Therapeutics	DermatologyInfectious Disease Rare	1	Phase 2	$282M	4
VNDA	Vanda Pharmaceuticals	CardiovascularDermatology+6 Rare	1	Approved	$231M	27
ZURA	Zura Bio	DermatologyImmunology Rare	1	Phase 2	$394M	5